Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • asiangg
    Member
    • Dec 2008
    • 44

    Bioinformatics Researcher – Next Generation Sequencing

    A postdoctoral position is open in Dr. Shen’s group at the Icahn School of Medicine at Mount Sinai in New York City. Our research mainly focuses on bioinformatic analysis of transcriptomic and epigenomic data for brain diseases, such as drug addiction and depression. We mainly work with next-generation sequencing (NGS) data which are generated from Mount Sinai’s sequencing core facility. We have accumulated more than three hundred ChIP-seq and RNA-seq samples, with much more coming in the next few years.

    You will use the most advanced statistical methods to analyze these data and make stories out of it. You will also develop novel approaches to optimize our use of these data and build applications. If you are very quantitative in mind, like to deal with large volume of data and love challenges, this is a wonderful opportunity!

    Our effort to advance the analysis of NGS data can be demonstrated by the following software development:

    diffReps – differential analysis for ChIP-seq: https://code.google.com/p/diffreps/
    ngs.plot – biological hypotheses testing with NGS data: https://code.google.com/p/ngsplot/

    We will continue to develop these software which have proved to be very useful for researchers in the field. We wish you can be part of this exciting journey!

    My group also collaborates with multiple investigators in the department, such as Drs. Eric Nestler, Yasmin Hurd, Schahram Akbarian and Scott Russo, who are world-renowned neuroscientists. We are very well funded and are determined to do the best quality research. For more information, please visit: http://neuroscience.mssm.edu/shen/

    Requirements:
    - Ph.D. in computer science, computational biology, bioinformatics or related fields.
    - Strong problem solving skills.
    - “Can do” attitude with some hacker’s spirits.
    - Excellent knowledge with statistics and data mining techniques.
    - Good knowledge about molecular biology, genomics and sequencing technology.
    - Strong programming skills with scripting languages such as Perl, Python or PHP.
    - Strong skills with statistical computing platforms; R preferred.
    - Working experience with distributed systems and cloud computing a strong plus.
    - Working experience with Linux operating system a must.
    - Excellent communication and presentation skills.

    Interested person should send his/her CV along with at least two references to [email protected]

    Open immediately!

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
214 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
79 views
0 reactions
Last Post SEQadmin2  
Working...